Загрузка...
(Not Giving Up) The Marathon Race of MET Targeting Therapy - Are We There Yet?
Among various MET aberrations, MET amplification and METex14 have emerged as valid predictive biomarkers for MET inhibition. Despite challenges that have limited the development of MET inhibitors, we can learn from the latest efforts in biomarker-based therapy to better identify the patients who wil...
Сохранить в:
| Опубликовано в: : | Clin Cancer Res |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504968/ https://ncbi.nlm.nih.gov/pubmed/30770350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3739 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|